-
-
-
-
-
-
-
UPDATE: Rigel Pharmaceuticals (RIGL) PT Raised to 'Street High' $15 at H.C. Wainwright, Suggesting 800% Upside
-
-
-
-
-
-
-
Rigel Pharma (RIGL) Gains on Talk of FDA Approval
-
-
-
-
-
-
-
Rigel Pharma (RIGL) to Present One-Year Efficacy, Safety Results for Fostamatinib in ITP at ASH
-
-
-
-
-
-
-
Rigel Announces Second Quarter 2017 Financial Results and Provides Company Update
-
-
-
-
-
15,464 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

